Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05396521 · ClinicalTrials.gov registry record · NA

BFR Therapy Following DRF

A NA study, sponsored by Carilion Clinic.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT05396521: Completed NA study, sponsored by Carilion Clinic.

NCT05396521 is a NA study that has completed, run by Carilion Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05396521, a NA study, has completed, sponsored by Carilion Clinic.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This study's goal is to evaluate whether blood flow restriction supplemented therapy is a superior therapy compared to traditional standard of care while recovering from a surgery that repairs distal radius fractures. In order to measure this, subjects will be randomly assigned to either the traditional therapy group (with standard of care) or a blood flow restriction supplemented therapy group. All patients involved in this study will have had a distal radius fracture that is repaired with a technique called volar plating and the procedure will be done via an open technique. All subjects will be asked to fill out questionnaires that assess their pain and wrist functionality throughout the course of the study. These measurements will help understand whether the supplemented therapy is effective at reducing pain and improving functionality for patients who are recovering from this injury.

Interventions

  • OTHER Standard of Care Physical Therapy
  • OTHER Blood Flow Restriction

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2022-05-26
Est. Completion 2023-05-08
Phase NA
Carilion Clinic

45 total trials

What the finished NCT05396521 record still lists

NCT05396521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care Physical Therapy is the first listed.

NCT05396521 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05396521 about?

NCT05396521 is a clinical study titled "BFR Therapy Following DRF". This study's goal is to evaluate whether blood flow restriction supplemented therapy is a superior therapy compared to traditional standard of care while recovering from a surgery that repairs distal radius fractures. In order to measure this, subjects will be randomly assigned to either the traditi...

What is the current status of trial NCT05396521?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2022-05-26. Estimated completion is 2023-05-08.

What interventions are being tested in trial NCT05396521?

The interventions under investigation include: Standard of Care Physical Therapy (OTHER), Blood Flow Restriction (OTHER).

Who is sponsoring clinical trial NCT05396521?

This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05396521's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05396521, the US trial registry maintained by the National Library of Medicine. NCT05396521 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.